Christopher F. Massey

ORCID: 0000-0001-9321-1955

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy”.

The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy

Cancer Immunology Research(2025)10.1158/2326-6066.cir-24-1191

N/A

0.345DataRank · unranked

9 citations

Julia Sheehan‐Klenk, Joseph J. Grudzinski, David P. Adam, Thanh Phuong T. Nguyen, Carolina A. Ferreira +24 more

Immunomodulatory effects of alpha vs beta radiopharmaceutical therapy in murine prostate cancer

Frontiers in Immunology(2025)10.3389/fimmu.2025.1563387

N/A

0.345DataRank · unranked

9 citations

Hemanth K. Potluri, Mojdeh Mahmoudian, Christopher F. Massey, Joseph J. Grudzinski, Amanda Carston +15 more

870 High-dose radiation is required for effective combination with tumor-specific vaccination in a prostate cancer model

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0870

N/A

0DataRank · unranked

0 citations

Carolina A. Ferreira, Joseph J. Grudzinski, Christopher F. Massey, Reinier Hernandez, Jamey P. Weichert +2 more